Publications
Found 1 results
Filters: Author is Z.S. Özkan [Clear All Filters]
“Lack of effect of bone morphogenetic protein 2 and 4 gene polymorphisms on bone density in postmenopausal Turkish women”, vol. 9, pp. 2311-2316, 2010.
, Baylink DJ, Strong DD and Mohan S (1999). The diagnosis and treatment of osteoporosis: future prospects. Mol. Med. Today 5: 133-140.
http://dx.doi.org/10.1016/S1357-4310(98)01426-9
Brochmann EJ, Behnam K and Murray SS (2009). Bone morphogenetic protein-2 activity is regulated by secreted phosphoprotein-24 kd, an extracellular pseudoreceptor, the gene for which maps to a region of the human genome important for bone quality. Metabolism 58: 644-650.
http://dx.doi.org/10.1016/j.metabol.2009.01.001
PMid:19375587
Choi JY, Shin CS, Hong YC and Kang D (2006). Single-nucleotide polymorphisms and haplotypes of bone morphogenetic protein genes and peripheral bone mineral density in young Korean men and women. Calcif. Tissue Int. 78: 203-211.
http://dx.doi.org/10.1007/s00223-005-0139-z
PMid:16604289
Ferrari S (2008). Human genetics of osteoporosis. Best Pract. Res. Clin. Endocrinol. Metab. 22: 723-735.
http://dx.doi.org/10.1016/j.beem.2008.08.007
PMid:19028354
Flicker L, Hopper JL, Rodgers L, Kaymakci B, et al. (1995). Bone density determinants in elderly women: a twin study. J. Bone Miner. Res. 10: 1607-1613.
http://dx.doi.org/10.1002/jbmr.5650101102
PMid:8592936
Ichikawa S, Johnson ML, Koller DL, Lai D, et al. (2006). Polymorphisms in the bone morphogenetic protein 2 (BMP2) gene do not affect bone mineral density in white men or women. Osteoporos. Int. 17: 587-592.
http://dx.doi.org/10.1007/s00198-005-0018-5
PMid:16432645
Ireland P, Jolley D, Giles G, O'Dea K, et al. (1994). Development of the Melbourne FFQ: a food frequency questionnaire for use in an Australian prospective study involving an ethnically diverse cohort. Asia Pac. J. Clin. Nutr. 3: 19-31.
Mangino M, Torrente I, De Luca A, Sanchez O, et al. (1999). A single-nucleotide polymorphism in the human bone morphogenetic protein-4 (BMP 4) gene. J. Hum. Genet. 44: 76-77.
http://dx.doi.org/10.1007/s100380050113
PMid:9929985
Medici M, van Meurs JB, Rivadeneira F, Zhao H, et al. (2006). BMP-2 gene polymorphisms and osteoporosis: the Rotterdam Study. J. Bone Miner. Res. 21: 845-854.
http://dx.doi.org/10.1359/jbmr.060306
PMid:16753015
Ramesh Babu L, Wilson SG, Dick IM, Islam FM, et al. (2005). Bone mass effects of a BMP4 gene polymorphism in postmenopausal women. Bone 36: 555-561.
http://dx.doi.org/10.1016/j.bone.2004.12.005
PMid:15777683
Richards JB, Rivadeneira F, Inouye M, Pastinen TM, et al. (2008). Bone mineral density, osteoporosis, and osteoporotic fractures: a genome-wide association study. Lancet 371: 1505-1512.
http://dx.doi.org/10.1016/S0140-6736(08)60599-1
Richards JB, Kavvoura FK, Rivadeneira F, Styrkarsdottir U, et al. (2009). Collaborative meta-analysis: associations of 150 candidate genes with osteoporosis and osteoporotic fracture. Ann. Intern. Med. 151: 528-537.
http://dx.doi.org/10.7326/0003-4819-151-8-200910200-00006
PMid:19841454 PMCid:2842981
Rivadeneira F, Styrkarsdottir U, Estrada K, Halldorsson BV, et al. (2009). Twenty bone-mineral-density loci identified by large-scale meta-analysis of genome-wide association studies. Nat. Genet. 41: 1199-1206.
http://dx.doi.org/10.1038/ng.446
PMid:19801982 PMCid:2783489
Sengle G, Charbonneau NL, Ono RN, Sasaki T, et al. (2008). Targeting of bone morphogenetic protein growth factor complexes to fibrillin. J. Biol. Chem. 283: 13874-13888.
http://dx.doi.org/10.1074/jbc.M707820200
PMid:18339631 PMCid:2376219
Styrkarsdottir U, Cazier JB, Kong A, Rolfsson O, et al. (2003). Linkage of osteoporosis to chromosome 20p12 and association to BMP2. PLoS Biol. 1: E69.
http://dx.doi.org/10.1371/journal.pbio.0000069
PMid:14691541 PMCid:270020
Takahashi T, Morris EA and Trippel SB (2007). Bone morphogenetic protein-2 and -9 regulate the interaction of insulin-like growth factor-I with growth plate chondrocytes. Int. J. Mol. Med. 20: 53-57.
PMid:17549388
Wang EA, Rosen V, D'Alessandro JS, Bauduy M, et al. (1990). Recombinant human bone morphogenetic protein induces bone formation. Proc. Natl. Acad. Sci. U. S. A. 87: 2220-2224.
http://dx.doi.org/10.1073/pnas.87.6.2220
PMid:2315314 PMCid:53658
Young D, Hopper JL, Nowson CA, Green RM, et al. (1995). Determinants of bone mass in 10- to 26-year-old females: a twin study. J. Bone Miner. Res. 10: 558-567.
http://dx.doi.org/10.1002/jbmr.5650100408
PMid:7610926
Zhou H, Qian J, Wang J, Yao W, et al. (2009). Enhanced bioactivity of bone morphogenetic protein-2 with low dose of 2-N, 6-O-sulfated chitosan in vitro and in vivo. Biomaterials 30: 1715-1724.
http://dx.doi.org/10.1016/j.biomaterials.2008.12.016
PMid:19131102